Effects of testosterone, dihydrotestosterone, or estradiol administered neonatally on sexual behavior of female ferrets.
Groups of female ferrets born in the laboratory received sc Silastic capsules containing testosterone (T), 5 alpha-dihydrotestosterone (DHT), 17 beta-estradiol (E), or no steroid for 15 days beginning on the day of birth; an additional group of male ferrets received empty sc capsules neonatally. All ferrets were gonadectomized at 11 weeks of age and were subsequently tested for masculine and feminine sexual behaviors while being treated consecutively over an 8-month period with several different gonadal steroids. The ability to display masculine sexual behavior was studied in the absence of replacement hormones and during a counterbalanced sequence of treatments with Silastic capsules containing T, E, or DHT. The maximal amount of neck grip, mount, and pelvic thrusting behavior displayed, regardless of adult endocrine treatment, was significantly greater in control male and neonatally T-treated females than in females that had received no hormone, E, or DHT neonatally. Animals in all five groups displayed equivalent increments in sexual receptivity in response to daily sc injections of increasing dosages of estradiol benzoate. Polyacrylamide gel electrophoresis of plasma collected from newborn female ferrets revealed no binding of either [3H]E or [3H]T, whereas two binding peaks were found for [3H]DHT. After the administration of androgen in adulthood, equivalent clitoral growth and ossification occurred in females given either T or DHT neonatally. These results suggest that in ferrets, behavioral masculinization occurs in response to neonatal exposure to T itself and not to its major neural metabolites, E and DHT. They also show that behavioral defeminization fails to occur in ferrets even after neonatal exposure to pharmacological amounts of E, T, or DHT.
D000818:Animals; D000831:Animals, Newborn / Q000254:growth & development*; D001835:Body Weight / Q000187:drug effects; D003692:Delayed-Action Preparations; D013196:Dihydrotestosterone / Q000494:pharmacology*; D004591:Electrophoresis, Polyacrylamide Gel; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D005835:Genitalia / Q000187:drug effects; D011247:Pregnancy; D012726:Sexual Behavior, Animal / Q000187:drug effects*; D013739:Testosterone / Q000494:pharmacology*
D003692:Delayed-Action Preparations; D013196:Dihydrotestosterone; D013739:Testosterone; D004958:Estradiol